BioLife Solutions Inc (BLFS)

Receivables turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 142,796 154,008 161,427 162,452 161,032 154,468 147,521 138,192 118,837 96,581 74,057 52,773 48,087 41,249 36,673 33,590 27,367 25,090 23,762 22,134
Receivables US$ in thousands 18,657 24,556 26,860 30,343 33,936 32,436 31,257 24,271 23,217 20,232 21,093 10,669 8,006 6,095 4,351 8,205 5,345 4,313 3,832 2,927
Receivables turnover 7.65 6.27 6.01 5.35 4.75 4.76 4.72 5.69 5.12 4.77 3.51 4.95 6.01 6.77 8.43 4.09 5.12 5.82 6.20 7.56

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $142,796K ÷ $18,657K
= 7.65

The receivables turnover ratio measures how efficiently a company is able to collect cash from customers on credit sales. It is calculated by dividing net credit sales by average accounts receivable. A higher receivables turnover indicates that the company is collecting its receivables more quickly.

BioLife Solutions Inc's receivables turnover has shown fluctuations over the past few quarters. The ratio has ranged from 3.51 to 8.43 during the period from March 2019 to December 2023. Generally, a higher turnover ratio is preferred as it signifies more efficient management of receivables.

In the latest quarter, ending December 31, 2023, BioLife Solutions Inc achieved a receivables turnover ratio of 7.65, indicating that the company collected its receivables 7.65 times during the year. This suggests a significant improvement in the efficiency of receivables collection compared to previous quarters. It's essential for the company to maintain a consistent and relatively high receivables turnover ratio to ensure a healthy cash flow and efficient management of working capital.


Peer comparison

Dec 31, 2023